Kennedy Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,131	Closed	-$64.2K	–	738
2024 Q1	$64.2K	Buy	+17,131	New	+$100K	﹤0.01%	720
2023 Q3	–	Sell	-27,012	Closed	-$359K	–	701
2023 Q2	$359K	Buy	+27,012	New	+$328K	0.01%	625
2023 Q1	–	Sell	-241,727	Closed	-$1.98M	–	640
2022 Q4	$1.98M	Sell	241,727 -107,200	-31%	-$924K	0.06%	415
2022 Q3	$2.03M	Buy	+348,927	New	+$2M	0.06%	414
2022 Q1	–	Sell	-220,106	Closed	-$4.5M	–	626
2021 Q4	$4.5M	Buy	220,106 +134,269	+156%	+$3.24M	0.09%	369
2021 Q3	$2.19M	Buy	+85,837	New	+$2.54M	0.05%	467
2017 Q3	–	Sell	-1,240,391	Closed	-$4.42M	–	754
2017 Q2	$4.42M	Buy	1,240,391 +426,269	+52%	+$1.72M	0.08%	440
2017 Q1	$4.21M	Buy	814,122 +961	+0.1%	+$4.7K	0.07%	462
2016 Q4	$3.09M	Buy	813,161 +685,080	+535%	+$4.98M	0.05%	525
2016 Q3	$1.15M	Buy	+128,081	New	+$1.07M	0.02%	644